MD HB25 | 2019 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 4-0)
Status: Introduced on January 9 2019 - 25% progression
Action: 2019-01-09 - First Reading Health and Government Operations
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requiring, instead of authorizing, the Prescription Drug Monitoring Program to review prescription monitoring data for indications of a possible misuse or abuse of a monitored prescription drug; requiring the Program to report the possible misuse or abuse to the prescriber or dispenser of the monitored prescription drug and to provide certain education to the prescriber or dispenser; authorizing the Program to provide prescription monitoring data to the Office of Controlled Substances Administration for further investigation; etc.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Public Health - Prescription Drug Monitoring Program - Revisions

Sponsors


History

DateChamberAction
2019-01-09HouseFirst Reading Health and Government Operations
2018-09-11HousePre-filed

Subjects


Maryland State Sources


Bill Comments

feedback